4-[7-[3-(difluoromethyl)-1-methylpyrazol-4-yl]-2-methyl-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole
C18H17F2N5O — CID 121442923
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[7-[3-(difluoromethyl)-1-methylpyrazol-4-yl]-2-methyl-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole
4-[7-[3-(difluoromethyl)-1-methylpyrazol-4-yl]-2-methyl-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole (PubChem CID 121442923) has the molecular formula C18H17F2N5O and a molecular weight of 357.36 g/mol. Its IUPAC name is 4-[7-[3-(difluoromethyl)-1-methylpyrazol-4-yl]-2-methyl-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole.
Molecular Properties
| Compound Name | 4-[7-[3-(difluoromethyl)-1-methylpyrazol-4-yl]-2-methyl-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole |
|---|---|
| PubChem CID | 121442923 |
| Molecular Formula | C18H17F2N5O |
| Molecular Weight | 357.36 g/mol |
| Exact Mass | 357.14 |
| IUPAC Name | 4-[7-[3-(difluoromethyl)-1-methylpyrazol-4-yl]-2-methyl-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole |
| SMILES | Cc1nc2c(-c3cn(C)nc3C(F)F)cc(-c3c(C)noc3C)cc2[nH]1 |
| InChI | InChI=1S/C18H17F2N5O/c1-8-15(9(2)26-24-8)11-5-12(16-14(6-11)21-10(3)22-16)13-7-25(4)23-17(13)18(19)20/h5-7,18H,1-4H3,(H,21,22) |
| InChIKey | JTBRRSWLNRFAPN-UHFFFAOYSA-N |
| XLogP | 4.48 |
| TPSA | 72.53 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 357.36 |
| LogP ≤ 5 | 4.48 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121442923 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.